Fulcrum Therapeutics, Inc. (FULC) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Fulcrum Therapeutics, Inc. (FULC) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $392.3M, listed on NASDAQ, employing roughly 45 people, carrying a beta of 3.01 to the broader market. Fulcrum Therapeutics, Inc. Led by Alexander C. Sapir, public since 2019-07-18.
Snapshot as of May 14, 2026.
- Spot Price
- $7.14
- Total OI
- 12.9K